Wordt geladen...
Evolving Therapeutic Strategies for the Classic Philadelphia-Negative Myeloproliferative Neoplasms
Despite the emergence of JAK inhibitors, there is a need for disease-modifying treatments for Philadelphia-negative myeloproliferative neoplasms (MPNs). JAK inhibitors ameliorate symptoms and address splenomegaly, but because of the heterogeneous contributors to the disease process, JAK inhibitor mo...
Bewaard in:
| Gepubliceerd in: | EBioMedicine |
|---|---|
| Hoofdauteurs: | , , , , |
| Formaat: | Artigo |
| Taal: | Inglês |
| Gepubliceerd in: |
Elsevier
2016
|
| Onderwerpen: | |
| Online toegang: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4739416/ https://ncbi.nlm.nih.gov/pubmed/26870834 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ebiom.2016.01.010 |
| Tags: |
Voeg label toe
Geen labels, Wees de eerste die dit record labelt!
|